Volume 18; Issue supp-S1

Main
Clinical Therapeutics
Volume 18; Issue supp-S1

Clinical Therapeutics

Volume 18; Issue supp-S1

1

Pharmacoeconomics and outcomes research—visions for the 21st century

WilliamF. McGhan

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

2

The future of pharmacoeconomics: bridging science and practice

Michael Drummond

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 48 KB

english, 1996

3

I1. Guidelines for economic evaluation of pharmaceuticals: Canada's practical experiences

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

4

I2. Guidelines for economic evaluation of pharmaceuticals: Australia—an evolutionary process

AndrewS. Mitchell

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

5

I3. Pharmacoeconomic evaluations: a pharmaceutical company's perspective

LouisP. Garrison Jr.

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

6

I4. Regulating pharmacoeconomic information: prospects for public and private review in the United States

PeterJ. Neumann

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 81 KB

english, 1996

7

I5. Draft association for pharmacoeconomics and outcomes research consensus guidance for economic evaluation of pharmaceutical therapy: the health care provider's perspective

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 58 KB

english, 1996

8

16. A report of the expert panel on cost-effectiveness in health and medicine (sponsored by the US public health service)

MarkScott Kamlet

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 60 KB

english, 1996

9

17. Just the FACCTS—the consumers' perspective on outcomes accountability

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 60 KB

english, 1996

10

18. Providing cost-effective therapy using pharmacoeconomic evaluations: the US public sector approach

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 57 KB

english, 1996

11

I9. Using pharmacoeconomic research in hospital formulary decisions

GeneA. Gibson, Patricia Wolfangel

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 59 KB

english, 1996

12

I11. Applications of large databases to evaluate cost-effective therapy

RenéeJ. Goldberg Arnold

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

13

I12. Statistical considerations in cost-effectiveness evaluations

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 66 KB

english, 1996

14

I13. Advances in statistical considerations in prospective pharmacoeconomic studies

RobertH. Bigelow

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 53 KB

english, 1996

15

C1. The use of technology assessment and disease management by managed-care pharmacy in the United States

B.R. Luce, A. Lyles

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 68 KB

english, 1996

16

C2. Guidelines for the use of claims databases for outcomes research

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 66 KB

english, 1996

17

C3. A cost-density analysis of benign prostatic hyperplasia

S. Lanes, S. Sulsky, A. Walker, J. Isen, C. Grier, B. Lewis, N. Dreyer

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

18

C4. Cost-effectiveness trends of HMG-CoA reductase inhibitor therapy in a managed-care population

A. Petitta, R.E. Ward, J.V. Anandan, S.J. Beis, A.M. Johnson

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

19

C5. Beyond acute care: the true cost of stroke

J.A. O'Brien, J.J. Caro, W.S. Klittich

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 78 KB

english, 1996

20

C6. Diagnosis of osteoporosis: use of a prescreen questionnaire

E. Lydick, J. Turpin, C. Byrnes, T. Abbott, M. Melton, M. Berger

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 64 KB

english, 1996

21

C7. Hip fractures in the United States: direct medical expenditures within subgroups

A. Martin, R. Holmes, E. Lydick

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 66 KB

english, 1996

22

C8. Cost-effectiveness of paclitaxel in advanced ovarian cancer

M. Riviere, D. Rindress, E. Souetre

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996

23

C9. A canadian pharmacoeconomic evaluation of zinecard

T. Williamson, M. Bates, P. Crisp

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 129 KB

english, 1996

24

C10. Economic evaluation of simvastatin in the secondary prevention of coronary heart disease in canada

M. Riviere, C. Fitzsimon, C. Leclerc, R. Tretiak

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 58 KB

english, 1996

25

C11. Clinical and economic effects of Helicobacter pylori screening to prevent gastric cancer

A.M. Fendrick, M.E. Chernew, R.A. Hirth, J.M. Scheiman

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 71 KB

english, 1996

26

C12. Management and patients with past documented duodenal ulcer but unknown Helicobacter pylori status

A.M. Fendrick, J.T. McCort

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 58 KB

english, 1996

27

C13. Application of medicare databases to a theoretical renal transplant markov model

R.Goldberg Arnold, K. Pettit, J. DiCesare, D. Canafax, R. Lewis, D. Kaniecki

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 65 KB

english, 1996

28

C14. International economic evaluation of riluzole

C. Leclerc, R. Tretiak, M. Riviere

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996

29

C15. The economic impact of tacrine in the treatment of Alzheimer's disease

C. Henke, M. Burchmore

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

30

C16. Evaluating quality-of-life and health status instruments: development of scientific review criteria

K. Lohr, N. Aaronson, J. Alonso, A. Burnam, D. Patrick, E. Perrin, J. Roberts

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 80 KB

english, 1996

31

C17. Combining multiple quality-of-life domains into aggregate outcome measures: a second-order factor approach

R. Lennox, J. Scott-Lennox

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 70 KB

english, 1996

32

C18. Testing the constant proportional trade-off assumption using standard gamble

M. Bala, L. Wood, G. Zarkin, E. Norton, A. Gafni, B. O'Brien

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

33

C19. Quality-adjusted life-years and healthy years equivalent: an empiric comparison

L.L. Wood, B.V. Bala, E.C. Norton, G.A. Zarkin, A. Gafni, B. O'Brien

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 69 KB

english, 1996

34

C20. Willingness to pay to avoid minor postanesthetic symptoms

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 58 KB

english, 1996

35

C21. The impact of fears on quality of life in a silent disease (osteoporosis)

E. Lydick, B. Yawn, A. Martin, R. Holmes

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 64 KB

english, 1996

36

C22. Evaluation of community pharmacy-based anticoagulation clinics

R. Corey, C. Knowlton, O. Voltis Thomas

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 65 KB

english, 1996

37

C23. Comparative cost outcomes of inhaled corticosteroids for the treatment of asthma

S. Holzer, L. Engelhart

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 60 KB

english, 1996

38

C24. The utilization of a new nonsteroidal anti-inflammatory drug in a health maintenance organization

J. Rader, B. Goppold

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 68 KB

english, 1996

39

C25. International comparison of the cost of red cell transfusion: Canada and France

E. Souetre, R. Tretiak, M. Riviere, W. Qing, L. Girard

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 71 KB

english, 1996

40

C26. Costs of human immunodeficiency virus+/acquired immunodeficiency syndrome at CD4+ counts using treatment protocols

C. Gable, J. Tierce, D. Simison, D. Ward, K. Motte

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

41

C27. A review of pharmacoeconomic studies in Japan

S. Ikeda, N. Noguchi, A. Oliver, N. Ikegami

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 78 KB

english, 1996

42

C28. Contribution of quasi-experimental research designs in pharmacoeconomic studies: empiric data from a case study of antiviral therapy

R.F. Itzler, K.N. Simpson, A.K. Biddle, J.E. Veney

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 59 KB

english, 1996

43

C29. Latent variable models of health care utilization and costs for use in pharmacoeconomic research

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 69 KB

english, 1996

44

C30. Methodologic issues in pharmacoeconomic evaluations of HMG-CoA reductase inhibitors used in the treatment of hyperlipidemia

S.X. Kong, S.K. Gandhi, S.Y. Crawford

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 109 KB

english, 1996

45

P1. Information management technologies in outcomes research

Z.M. Khan, J. Smeeding, J. Koeller

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 63 KB

english, 1996

46

P2. Compromising optimal ambulatory resource utilization: evidence from health services prescribing associated with pharmaceutical products

S. Duttagupta, R.L. Mikeal

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 72 KB

english, 1996

47

P3. The impact of physician and parent conformance with practice parameters on outcomes of pediatric gastroenteritis

N. Merrick, A. Chawla, S. Holzer, S. Fox

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 77 KB

english, 1996

48

P4. Cost demographics of prescribing patterns

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

49

P5. Present situation of pharmacoeconomic evaluation by Japanese pharmaceutical companies

S. Inoue, S. Kitazawa, A. Oliver, S. Ikeda, N. Ikegami

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 66 KB

english, 1996

50

P6. Practical issues in conducting pharmacoeconomic studies

R. Rajagopalan, J.E. Kallal, J.F. Fowler Jr., E.F. Sherertz

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 77 KB

english, 1996

51

P7. Suboptimal prescribing and related outcomes in the nursing home medicaid elderly

S. Gupta, H. Rappaport

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

52

P8. A payer perspective cost-benefit analysis of felbamate in a managed-care setting

E.G. Klein, J.A. Paladino

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

53

P9. Patient outcomes: documentation of cost savings and cost avoidance

A. Mutnick, K. Sterba, H.J. Black

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 60 KB

english, 1996

54

P10. Economic evaluation of drug utilization review on medicaid pharmacy dispensing behavior: an empiric marginal analysis

J.J. Guo, J.T. Gibson, K.N. Barker

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996

55

P11. Effects of drug utilization review on medicaid prescriber behavior: a latent means modeling analysis

J.J. Guo, G.R. Hancock, J.T. Gibson, K.N. Barker

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 132 KB

english, 1996

56

P12. Costs of prescription drugs for diabetes mellitus medicaid patients in Alabama: a population-based study

J.J. Guo, J.T. Gibson, K.N. Barker

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 60 KB

english, 1996

57

P13. Power calculations for peptic disease utilization and expenditure studies

M. Cleary, C. Walters, T. Bernhardt, S. Foldes, S.B. Ho

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 76 KB

english, 1996

58

P14. Prevalence rates of antidepressant treatment by sex, age, and health plan

J. Garrard, M. Cleary, A. Heaton

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 76 KB

english, 1996

59

P15. Rate of esophageal dilations after the introduction of omeprazole

M. Cleary, S.B. Ho

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996

60

P16. Ketorolac does not preemptively reduce postoperative pain following laparoscopic tubal surgery

V.C. Lee, S.J. Lewis

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

61

P17. Comparison of family costs of two childhood illnesses—varicella and otitis media

E. Lydick, B. Yawn

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

62

P18. Evaluating red blood cell transfusions using a large clinical database

D. Ollendorf, G. Gordon, D. Throop, P. Steen, L. Berberian

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 70 KB

english, 1996

63

P19. Affectivity and affects balance as highly sensitive measures of psychological outcome and well-being in trials with medical and psychiatric populations

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 71 KB

english, 1996

64

P20. Patient electronic medical record—applications for a new age of treatment data

K. Copeland, J. Doyle

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

65

P21. Pharmacoeconomic analysis in the formulary decision-making process

P. Duong, N. Johnson

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 76 KB

english, 1996

66

P22. Quinolone selection in a for-profit hospital: a model for pharmacoeconomics

T.L. Williams, A. Goetz, E. Agbara, B. David

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 72 KB

english, 1996

67

P23. A comparison of the current status of pharmacoeconomic research in Japan and the United States

M.L. Watrous, G.P. Hess, A. Grogg, C.M. Kozma, M.D. Smith, H. O'chi, N. Tanaka, T. Kuwayama

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

68

P24. Cost-prevention analysis: a new term for a familiar analysis

C. Copley-Merriman, D. Kraemer, W. Maier, J. Carr, F. Luscombe

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 84 KB

english, 1996

69

P25. PRISM: delivering the pharmacoeconomic message

J.J. Caro, J.A. O'Brien, W.S. Klittich

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 76 KB

english, 1996

70

P26. Mobile computing with personal digital assistants in a clinical setting

N. Freedman, J. Apathy, I. Pollock

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

71

P27. A global renal outcomes study using unique data collection and analysis tools

A. Chahal, J. Blander, C. Tuck-Sherman

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

72

P28. The use of markov models in the pharmacoeconomic evaluation of relapsing/remitting diseases

M. Hagan, Z. Ying

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 69 KB

english, 1996

73

P29. Use and influence of pharmacoeconomics in decision making in hospitals

M. Gore, J. Thomas

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 67 KB

english, 1996

74

P30. The value of pharmacoeconomics in medicare/medicaid programs

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996

75

P31. Pharmacoeconomic evaluation of oral therapies for onychomycosis: a US model

A. Marchetti, B. Smith, C. Piech, W. McGhan, A. Neugut

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

76

P32. Influence of infection on length of hospital stay, mortality, and postdischarge level of care after surgical procedures

A.W. Bakst, P. Vacani, P. Watson, J.T. Dipiro, M. Miller

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 66 KB

english, 1996

77

P33. Staged diabetes management: a complete disease state management

B.H. Ginsberg, R. Mazze

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 48 KB

english, 1996

78

I10. Integration of inpatient and outpatient services: utilizing pharmacoeconomic and outcomes research to guide the way

Journal:

Clinical Therapeutics

Year:

1996

Language:

english

File:

PDF, 74 KB

english, 1996